Recent studies suggest that severity of asthma can be modulated by neuropsychiatric conditions, while the underlying mechanisms are not clear. Here, we used ovalbumin (OVA) to induce asthma in APP/PS1 mice, a mouse model of Alzheimer’s disease (AD), or in their wildtype control C57BL/6J mice. We found that all hallmarks of asthma by OVA were significantly attenuated in APP/PS1 mice, compared to age- and gender-matched C57BL/6J mice. Interestingly, significantly higher number of regulatory T cells (Treg) was detected in the APP/PS1 mouse lung, compared to those in the C57BL/6J mouse lung. Since Foxp3 is crucial for differentiation of naive T cells into Treg and is the most important marker for Treg, we examined the Foxp3 levels in the T cells from the lung of these mice. We found that the Foxp3 levels in the APP/PS1 mouse lung were significantly higher than those in the C57BL/6J mouse lung, likely resulting from reduced Foxp3 promoter methylation. Thus, our study suggests that AD may affect severity of asthma through methylation control of Foxp3 promoter in T cells.
DoganciA, EigenbrodT, KrugN, De SanctisGT, HausdingM, ErpenbeckVJ, Haddad elB, LehrHA, SchmittE, BoppT, KallenKJ, HerzU, SchmittS, LuftC, HechtO, HohlfeldJM, ItoH, NishimotoN, YoshizakiK, KishimotoT, Rose-JohnS, RenzH, NeurathMF, GallePR, FinottoS (2005) The IL-6R alpha chain controls lung CD4+ CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest115, 313–325.
6.
TrzonkowskiP, SzmitE, MysliwskaJ, MysliwskiA (2006) CD4+ CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol119, 307–316.
7.
PyzikM, PiccirilloCA (2007) TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J Leukoc Biol82, 335–346.
8.
PalomaresO, RuckertB, JarttiT, KucuksezerUC, PuhakkaT, GomezE, FahrnerHB, SpeiserA, JungA, KwokWW, KalogjeraL, AkdisM, AkdisCA (2012) Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol129, 510–520, 520, e511-519.
9.
WangX, DarcyJ, CaiC, JinJ, BartkeA, CaoD (2018) Intestinal immunity in hypopituitary dwarf mice: Effects of age. Aging (Albany NY)10, 358–370.
10.
GuZ, TanW, JiJ, FengG, MengY, DaZ, GuoG, XiaY, ZhuX, ShiG, ChengC (2016) Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway. Aging (Albany NY)8, 1102–1114.
11.
DattaA, MoitraS, DasPK, MondalS, Omar FarukSM, HazraI, TripathiSK, ChaudhuriS (2017) Allergen immunotherapy modulates sensitivity of Treg cells to apoptosis in a rat model of allergic asthma. Immunotherapy9, 1239–1251.
12.
CiprandiG, SchiavettiI, RicciardoloFLM (2018) The impact of aging on outpatients with asthma in a real-world setting. Respir Med136, 58–64.
13.
BussePJ, BirminghamJM, CalatroniA, ManziJ, GoryachokovskyA, FontelaG, FedermanAD, WisniveskyJP (2017) Effect of aging on sputum inflammation and asthma control. J Allergy Clin Immunol139, 1808–1818e1806.
14.
ChotirmallSH, BurkeCM (2015) Aging and the microbiome: Implications for asthma in the elderly?Expert Rev Respir Med9, 125–128.
15.
KangJY, LeeSY, RheeCK, KimSJ, KwonSS, KimYK (2013) Effect of aging on airway remodeling and muscarinic receptors in a murine acute asthma model. Clin Interv Aging8, 1393–1403.
16.
MakinoS (2012) Asthma in the elderly and aging societies in Asia Pacific. Asia Pac Allergy2, 1–2.
17.
SaresellaM, CalabreseE, MarventanoI, PianconeF, GattiA, CalvoMG, NemniR, ClericiM (2010) PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis21, 927–938.
18.
TiihonenM, TaipaleH, TanskanenA, TiihonenJ, HartikainenS (2016) Incidence and duration of cumulative bisphosphonate use among community-dwelling persons with or without Alzheimer’s disease. J Alzheimers Dis52, 127–132.
19.
LonnroosE, KyyronenP, BellJS, van der CammenTJ, HartikainenS (2013) Risk of death among persons with Alzheimer’s disease: A national register-based nested case-control study. J Alzheimers Dis33, 157–164.
NiikuraY, IshiiT, MurakamiJ, NaritaT, FujitaY, NegishiH, TaketaniY, YamashitaN (2019) Age-related immune-modulating properties of seminal fluid that control the severity of asthma are gender specific. Aging (Albany NY)11, 707–723.
22.
DavisKL, MohsRC, MarinD, PurohitDP, PerlDP, LantzM, AustinG, HaroutunianV (1999) Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA281, 1401–1406.
23.
ParkE, AlbertiJ, MehtaP, DaltonA, SersenE, Schuller-LevisG (2000) Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down’s syndrome. Clin Immunol95, 62–69.
24.
LiK, ZhangX, YangL, WangXX, YangDH, CaoGQ, LiS, MaoYZ, TangST (2016) Foxp3 promoter methylation impairs suppressive function of regulatory T cells in biliary atresia. Am J Physiol Gastrointest Liver Physiol311, G989–G997.
25.
YangJ, YuanX, LvC, BaiR, ZhangL, RuangL, ZhangC, QuanXQ (2016) Methylation of the FOXP3 upstream enhancer as a clinical indicator of defective regulatory T cells in patients with acute coronary syndrome. Am J Transl Res8, 5298–5308.
